Paul Brown
14Patents
4h-index
21Co-inventors
60Inventor score
Filing activity: Jun 24, 1996 → Aug 27, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6201039A | Bone substitute composition comprising hydroxyapatite and a method of production therefor | Human Necessities | 78 | Expired |
| US11077059B2 | Electrospraying formation of particles including agents | Human Necessities | 8 | Active |
| US11459376B2 | Compositions and methods for the delivery of therapeutic biologics for treatment of disease | Human Necessities | 6 | Active |
| US11654112B2 | Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof | Performing Operations; Transporting | 5 | Active |
| US11717488B2 | Particle formation and morphology | Chemistry; Metallurgy | 4 | Active |
| US12115262B2 | Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof | Human Necessities | 3 | Active |
| US12178913B2 | Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof | Performing Operations; Transporting | 1 | Active |
| US6465490B1 | Sulfuric acid mono-[3({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6683094B2 | Antihistaminic piperidine derivatives and intermediates for the preparation thereof | Chemistry; Metallurgy | 1 | Expired |
| US6716986B2 | Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-YL}-hydroxy-methyl)-2-methoxy-phenyl]ester | Emerging Cross-Sectional Technologies | 1 | Expired |
| US12263249B2 | Formation of particles including agents | Human Necessities | 0 | Active |
| US6407119B1 | Antihistaminic piperidine derivatives and intermediates for the preparation thereof | General | 0 | Revoked |
| US12377050B2 | Methods of forming particles by continuous droplet formation and dehydration | Performing Operations; Transporting | 0 | Active |
| US12263253B2 | Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.